Medical Doctor Program year 2025 Reported 2022–2025 Source: CMS Open Payments, 2026 publication

Silvio Travalia

Interventional Cardiology Naples, FL Medical Doctor

NPI 1609937382 CMS profile 27957

399 9Th St N, #300, Naples, FL 34102

Open in the dashboard

General payments

$772

21 records reported · program years 2022–2025

Research payments

$0

Paid to them · None reported · program years 2022–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Silvio Travalia of Naples, FL is reported in the CMS Open Payments database as having received $772 across 21 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 10th percentile of Interventional Cardiology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

4 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $42 3
2024 General $468 7
2023 General $176 10
2022 General $85 1

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Silvio Travalia
  • Interventional Cardiology median
  • Middle half of Interventional Cardiology
  • National median

In program year 2025, general payments to Silvio Travalia were reported at $42. Among 6,173 Interventional Cardiology profiles paid that year, the median was $1,092 and the middle half received between $366 and $3,019.

Show as a table
Year Silvio Travalia Interventional Cardiology median Middle half National median
2019 $0 $1,097 $329–$3,048 $163
2020 $0 $473 $161–$1,480 $114
2021 $0 $677 $233–$1,827 $132
2022 $85 $978 $333–$2,724 $149
2023 $176 $1,136 $382–$2,986 $160
2024 $468 $1,181 $395–$3,326 $164
2025 $42 $1,092 $366–$3,019 $169

Breakdown

Who paid General payments · program years 2022–2025
  1. CVRx, Inc. $484 16 payments
  2. ViiV Healthcare Company $125 1 payment
  3. Impulse Dynamics (USA) Inc. $85 1 payment
  4. Boston Scientific Corporation $40 1 payment
  5. Novartis Pharmaceuticals Corporation $23 1 payment
  6. Pfizer Inc. $14 1 payment

Every payment, record by record

What the payments were for General payments · program years 2022–2025
  1. Food and Beverage $772 21 payments
Products named General payments · program years 2022–2025
  1. Barostim Neo System $484 16 payments
  2. OPTIMIZER Cardiovascular Device $85 1 payment
  3. OPTIMIZER Cardiovascular Device $85 1 payment
  4. WATCHMAN FLX $40 1 payment
  5. LEQVIO $23 1 payment
  6. ENTRESTO $23 1 payment
  7. VYNDAQEL $14 1 payment

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 15 drugs

Part D claims

465

Median for Cardiology: 2,533

Drug cost

$96,010

Median for Cardiology: $485,213

Branded share of claims

29.7%

Median for Cardiology: 25.7%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Eliquis Apixaban Brand 85 $62,888
Xarelto Rivaroxaban Brand 13 $16,584
Repatha Sureclick Evolocumab Brand 14 $12,333
Metoprolol Succinate Generic 64 $1,190
Rosuvastatin Calcium Generic 37 $809
Atorvastatin Calcium Generic 46 $461
Losartan Potassium Generic 32 $289
Clopidogrel Clopidogrel Bisulfate Brand 26 $283
Warfarin Sodium Generic 12 $221
Amlodipine Besylate Generic 25 $209

The 10 drugs with the highest cost, of 15 counted.

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 18,782 Part D prescribers listed as Cardiology; they describe a distribution and say nothing about conduct.

Records

21 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Interventional Cardiology in Florida

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record